FDA weighs regulating AI devices like doctors as TEMPO pilot tests generative AI
On 8 September the FDA was reported to be considering regulating AI-powered devices in a way similar to doctors, while the TEMPO pilot tests generative AI devices. Trade press examined the FDA's generative AI approach in a piece built around four questions.
Who is affected and how
- medtech company
- The approval pathway for generative AI devices is taking shape in the TEMPO pilot; it is worth following the participation criteria.
- doctor
- If devices are regulated by a doctor-like standard, questions of liability and oversight may change.
- health policy
- The FDA's direction could set a precedent for other regulators in handling autonomous AI.
Sources
- FDA Considers Regulating AI-Powered Devices Like Doctorslaw.com · Sep 8, 2026
- FDA Seeks Input For Regulating GenAI-Powered Medical Deviceslegal500.com · Sep 9, 2026
- FDA Seeks Input For Regulating GenAI-Powered Medical Devices - Healthcare - United Statesmondaq.com · Sep 9, 2026
- FDA Seeks Feedback on Potential Regulation of GenAI Medical Devicesthe hipaa journal · Sep 11, 2026
- FDA's TEMPO Pilot Tests Generative AI Devicesdistilinfo.com · Sep 7, 2026
- FDA TEMPO Pilot Skips AI Approval · Medowsmedows.ai · Sep 9, 2026
- 4 questions about the FDA’s approach to generative AImedtech dive · Sep 9, 2026
- 4 questions about the FDA’s approach to generative AI - MedTech Divemedtechdive.com · Sep 9, 2026 · magyar
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.